We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
167 result(s) found, displaying 101 to 110
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Insulin degludec (rys) and Insulin aspart (rys)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYZODEG 70/30 PENFILL 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA FLEXTOUCH insulin degludec (rys) 100 U/mL solution for injection multidose cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA PENFILL insulin degludec (rys) 100 U/mL solution for injection multidose cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRESIBA FLEXTOUCH insulin degludec (rys) 200 U/mL solution for injection multidose cartridge.
-
Prescription medicine registrationActive ingredients: insulin aspart (rys).
-
Prescription medicine registrationActive ingredients: insulin degludec (rys), insulin aspart (rys).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FIASP PENFILL insulin aspart (rys) 100 units/mL solution for injection 3 mL cartridge.